A team of scientists have discovered that blood-thinning drugs reduce chances of coronavirus-related deaths. According to the new research, patients administered anticoagulant medications within 24 hours of being admitted to hospital with Covid-19 are less likely to die than those who do not receive them.
The research, published in the British Medical Journal, studied the effect of prophylactic anticoagulation drugs on more than 4,000 COVID-19 infected people. The researchers stated that the findings provide strong real-world evidence to administer these drugs early as initial treatment for COVID-19 patients.
Additionally, patients getting decoagulants showed less risk of bleeding. Considering factors including age, ethnicity, medical conditions and weight, it was seen that 4.4 per cent were with fewer chances of death due to absolute terms than those who didn't receive the medications. The study showed a decreased relative risk of death by 34 per cent.
The researchers also acknowledged that due to the 'observational nature of the study', uncertainty exists that can be figured only through randomized trials. Another three studies found that blood-thinners also reduce the amount of time spend on ventilators by hospitalized COVID-19 patients.